Long-Term Complete Remission with nab-Paclitaxel, Bevacizumab, and Gemcitabine Combination Therapy in a Patient with Triple-Negative Metastatic Breast Cancer

By  

Case Reports in Oncology, Vol. 5, Iss. 3, 2012-12 ,pp. : 687-692

Karger

Access to resources Recommend Favorite

NCCTG N0879 (Alliance): A randomized phase 2 cooperative group trial of carboplatin, paclitaxel, and bevacizumab ± everolimus for metastatic melanoma

By  

CANCER, Vol. 124, Iss. 3, 2018-02 ,pp. : 537-545

John Wiley & Sons Inc

Access to resources Recommend Favorite

Feasibility and Toxicity of Weekly Paclitaxel-Carboplatin in 131 Patients with Pretreated and Non-Pretreated Solid Tumors

By  

Oncology Research and Treatment, Vol. 25, Iss. 2, 2002-05 ,pp. : 152-157

Karger

Access to resources Recommend Favorite

Preliminary Results of the Combination of Bevacizumab and Weekly Paclitaxel in Advanced Melanoma

By  

Oncology, Vol. 74, Iss. 1-2, 2008-06 ,pp. : 12-16

Karger

Access to resources Recommend Favorite

Durable Complete Remission of a Brainstem Glioma Treated with a Combination of Bevacizumab and Cetuximab

By  

Case Reports in Oncology, Vol. 5, Iss. 3, 2012-12 ,pp. : 676-681

Karger

Access to resources Recommend Favorite